TrialEuropean heart journal2019

N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels.

Veronica J Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.